Notwithstanding, low enrollment was the most common reason for trial failure every year between 2008 and 2018, and while other causes of failure remained relatively stable, low‐accrual failure showed a positive trend between 2008 and 2016.
← all excerpts
Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials.
1
—
—